New York Stem Cell Foundation Research Institute

NYSCF is now part of The Jackson Laboratory. This feed will no longer be updated, but our mission continues as we work together to advance discovery and improve human health. To stay up to date on all future news and events, please follow along at @jacksonlab.

Together, we’re redefining what’s possible.​ ​ With the acquisition of the New York Stem Cell Foundation, JAX is connecting the power of mouse, cell, and AI models to speed breakthroughs from discovery to therapy and transform the future of medicine.​ youtube.com/watch?v=TcYOEK…

I look forward to your remaining engaged in this impactful scientific community under the visionary leadership of JAX President and CEO Lon Cardon, Ph.D., FMedSci.”

On behalf of everyone at NYSCF, I thank you for championing our work to accelerate cures for all of our loved ones.

Statement from our President and CEO Jennifer Raab: “We are pleased to announce our next chapter: NYSCF was acquired today by The Jackson Laboratory (JAX) and joins the global @jacksonlab network as the JAX – NYSCF Collaborative.

By joining forces now to integrate our technologies and expertise, we are creating an extraordinary environment to accelerate cures and improve health worldwide.” Learn more about this inspiring agreement: nyscf.org/resources/pion…

Our organizations have long shared a deep commitment to innovative science that changes lives, and each organization has pioneered technologies that have revolutionized medical research to fight disease.

We are pleased to join our partner @jacksonlab (JAX) in announcing this historic alliance. As our President and CEO @nyscfpresident said:

Another fantastic panel discussion yesterday! Andrew Dunn of Endpoints News moderated a conversation on AI in Biomedicine with Anastasia Gamick (Convergent Research), Grant Mitchell, MD (Every Cure), Justin Scheer, PhD (Johnson and Johnson) and Vega Shah, PhD (NVIDIA) #2025NYSCF

A fantastic panel discussion moderated by Matthew Herper of STAT explored how science and capital intersect to drive innovation in biotech with Karen Heidelberger (Deerfield Management), John Mendlein (Flagship Pioneering), Viq Pervaaz (NYCEDC), Carlo Rizzuto (Versant Ventures).

Thank you to Dr. Maike Sander (Max Delbrück Center for Molecular Medicine) for delivering our Keynote Address! Dr. Sander shared how stem cell research is advancing our understanding of diabetes and how we can deliver these cells to patients.

NYSCF President Jennifer Raab gave opening remarks today to kick-off the #NYSCF2025 Conference!

What are the latest innovations in tissue engineering revealing about human development and disease? Join #NYSCF2025 to discover how organoids and organ-on-chip platforms are transforming toxicology testing and advancing new therapeutic approaches: conference.nyscf.org

Three weeks left until we kick off the #NYSCF2025 Conference! Join us @Hunter_College on Apr 15–16 to catch up on the latest stem cell science, and connect with 500+ attendees from academia, industry and nonprofits. View the full agenda and register here: conference.nyscf.org